Syringe access for the prevention of blood borne infections among injection drug users - Wikidata - wikimedia - TriplyDB

Syringe access for the prevention of blood borne infections among injection drug users

Syringe access for the prevention of blood borne infections among injection drug users

http://www.wikidata.org/entity/Q21257250

about

Access to syringes for HIV prevention for injection drug users in St. Petersburg, Russia: syringe purchase test study.Pharmacists and harm reduction: A review of current practices and attitudes.Approval of syringe exchange programs in California: results from a local approach to HIV prevention Deficit models and divergent philosophies: Service providers’ perspectives on barriers and incentives to drug treatment

P2860

Q30538400-617BA407-D819-4D8F-84C8-80175C60C077 Q36595859-F94AF87A-1E31-4975-B571-0F74B13AC713 Q56504559-B5E486D5-19FB-4E2A-BF09-7E60E0871FE2 Q56873976-FD756F2B-115C-473B-BF17-5E896B81D65A

P2860

Syringe access for the prevention of blood borne infections among injection drug users

http://www.wikidata.org/entity/Q21257250

description

2003 nî lūn-bûn

@nan

2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Syringe access for the prevention of blood borne infections among injection drug users

@ast

Syringe access for the prevention of blood borne infections among injection drug users

@en

Syringe access for the prevention of blood borne infections among injection drug users

@en-gb

Syringe access for the prevention of blood borne infections among injection drug users

@nl

type

label

Syringe access for the prevention of blood borne infections among injection drug users

@ast

Syringe access for the prevention of blood borne infections among injection drug users

@en

Syringe access for the prevention of blood borne infections among injection drug users

@en-gb

Syringe access for the prevention of blood borne infections among injection drug users

@nl

prefLabel

Syringe access for the prevention of blood borne infections among injection drug users

@ast

Syringe access for the prevention of blood borne infections among injection drug users

@en

Syringe access for the prevention of blood borne infections among injection drug users

@en-gb

Syringe access for the prevention of blood borne infections among injection drug users

@nl

P1433

Q21257250-F4A7DC3F-D81C-4B4F-B178-2B9433517FE1

P1476

Q21257250-2AF5DBFD-8477-4C90-861C-654EF4BA7833

P2093

Q21257250-2D912CFA-473B-4A3F-8DAB-186AAA31619B

Q21257250-44306426-5657-4F43-9A9D-F237E4550DB8

Q21257250-E9FFE71D-FA75-4BB3-B256-33E0C4F4E621

Q21257250-F6B4E71F-7151-41EC-B8E7-A6A21241B06F

P2860

Q21257250-03BE908D-4576-4AF3-A9BE-5CF90B801B22

Q21257250-03F8AB9B-17DF-44C9-8F2F-EA7B528040C3

Q21257250-2668AF47-4909-4B55-8BAA-B0346C028B74

Q21257250-37E3B414-C87E-46F7-9E52-F4C6B0D8CC51

Q21257250-38E35E21-BFDB-4A5A-9FD4-C180DB0B2E87

Q21257250-3C89FD9C-7DC8-41F8-8687-A7C94D857BA3

Q21257250-46E6635E-53EA-46B3-BCA4-AF25BE985AAA

Q21257250-58742598-F02A-4405-A1B1-0F7BE27E9441

Q21257250-6244F422-7F9C-40D2-8255-745B21115419

Q21257250-8371304C-9557-4BA7-B978-5D8ADBB46F5F

P2888

Q21257250-36273C79-1572-422D-9CDA-60712A847C15

P304

Q21257250-AD6BBC50-3D23-4B3A-8321-DAD6B406EB47

P31

Q21257250-A25967BF-790E-402B-89DC-E861B9735B8A

P356

Q21257250-0F22D244-BD64-4DD8-B624-CF74B91B7B05

P407

Q21257250-88ADCA51-F727-4B83-A415-4E0634076625

P433

Q21257250-EB98802E-6D87-46EF-A72C-61FDF2EC8B83

P478

Q21257250-1F790E77-BC31-4C3F-9BEE-E60781CE6C5E

P577

Q21257250-2B843415-2DE8-44B5-9D47-3EB9796AD8F8

P5875

Q21257250-3553AD3E-F0D6-4A63-93FC-F481ACFBBC3F

P6179

Q21257250-4117A710-4B0E-4293-BABD-CE65C4463DB1

P698

Q21257250-76903713-A44E-4649-8CD9-BE5AA7574925

P932

Q21257250-7FFD1F0F-2ED2-4470-935C-8057DE4D7E18

P356

P1433

BMC Public Health

P1476

Syringe access for the prevention of blood borne infections among injection drug users

@en

P2093

Bruce Agins

http://www.w3.org/2001/XMLSchema#string

Josiah D Rich

http://www.w3.org/2001/XMLSchema#string

Scott Burris

http://www.w3.org/2001/XMLSchema#string

Sharon Stancliff

http://www.w3.org/2001/XMLSchema#string

P2860

The cost-effectiveness of methadone maintenance.

Why physicians are unprepared to treat patients who have alcohol- and drug-related disorders.

Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV.

Needle-exchange attendance and health care utilization promote entry into detoxification.

Preventing blood-borne infections through pharmacy syringe sales and safe community syringe disposal.

State syringe and drug possession laws potentially influencing safe syringe disposal by injection drug users.

Human immunodeficiency virus infection in intravenous drug users: a model for primary care.

New York State pharmacists' attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation.

Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges.

Cost-effectiveness of syringe exchange as an HIV prevention strategy.

P2888

P304

37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2458-3-37

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2003-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8995389

http://www.w3.org/2001/XMLSchema#string

P6179

1038568548

http://www.w3.org/2001/XMLSchema#string

P698

14633286

http://www.w3.org/2001/XMLSchema#string

P932

317318

http://www.w3.org/2001/XMLSchema#string